ketoconazole has been researched along with Tinea in 89 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Tinea: Fungal infection of keratinized tissues such as hair, skin and nails. The main causative fungi include MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the synergistic effects of tetrandrine (TET) on the antifungal activity of topical ketoconazole (KCZ) in the treatment of dermatophytoses." | 9.15 | Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. ( Gao, AL; Shi, JP; Xiang, SB; Zhang, GH; Zhang, H; Zhang, ZD, 2011) |
| "An open, prospective, comparative, randomised and parallel-group study of 65 patients was conducted to evaluate the efficacy and safety of topical 1 % emulsion-gel of terbinafine versus 2% ketoconazole cream in the treatment of tinea corporis and tinea cruris." | 9.09 | Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. ( Bonifaz, A; Saúl, A, 2000) |
| "Thirty-five dermatologists enrolled 256 patients to assess the safety and efficacy of ketoconazole 2 percent cream, applied once daily, in the treatment of tinea pedis, tinea cruris, and tinea corporis." | 9.08 | Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis. ( Lester, M, 1995) |
| "A total of 40 patients with clinically and mycologically documented tinea corporis or tinea cruris were treated with 100 mg/day itraconazole (n = 19) or 500 mg/day griseofulvin (n = 21) for 15 days." | 9.07 | A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study. ( Chaidemenos, G; Chatzopoulou, E; Kalogeropoulou, A; Karakatsanis, G; Kousidou, T; Michailidis, D; Panagiotidou, D; Teknetzis, A, 1992) |
| "A multicenter double-blind study was conducted on the use of ketoconazole and griseofulvin for the treatment of dermatomycoses." | 9.05 | A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses. ( Daily, AD; Glogau, R; Jolly, HW; Krupp, I; Rex, IH; Stegman, SJ; Tromovitch, TA, 1983) |
| "In an open study 58 patients with chronic dermatophytosis mainly caused by Trichophyton rubrum and five patients with Tinea capitis were treated with ketoconazole." | 9.05 | Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis. ( Svejgaard, E, 1985) |
| " In this retrospective study, we aimed to analyze the response rate, efficacy, relapse rate, and side effects of oral ketoconazole (KZ) in the treatment of recalcitrant tinea corporis and cruris." | 8.02 | Real World Analysis of Response Rate and Efficacy of Oral Ketoconazole in Patients with Recalcitrant Tinea Corporis and Cruris. ( Arora, P; Kaur, R; Kulhari, A; Panesar, S; Rawat, D; Sardana, K, 2021) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 7.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 7.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| " Based on the pharmacokinetic profile, 100 mg itraconazole daily was then compared with 500 mg ultramicronized griseofulvin daily using a fixed treatment schedule of 15 days in tinea corporis and/or cruris and 30 days in tinea pedis and/or manus." | 6.67 | Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. ( Cauwenbergh, G; De Doncker, P; Janssen, PA; Lachapelle, JM; Tennstedt, D, 1992) |
| "One ketoconazole-treated patient relapsed within 7 days after cessation of therapy." | 6.66 | Double blind study of ketoconazole and griseofulvin in dermatophytoses. ( Bartlett-Coma, A; Martínez-Roig, A; Torres-Rodríguez, JM, 1988) |
| "To evaluate the synergistic effects of tetrandrine (TET) on the antifungal activity of topical ketoconazole (KCZ) in the treatment of dermatophytoses." | 5.15 | Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. ( Gao, AL; Shi, JP; Xiang, SB; Zhang, GH; Zhang, H; Zhang, ZD, 2011) |
| "An open, prospective, comparative, randomised and parallel-group study of 65 patients was conducted to evaluate the efficacy and safety of topical 1 % emulsion-gel of terbinafine versus 2% ketoconazole cream in the treatment of tinea corporis and tinea cruris." | 5.09 | Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. ( Bonifaz, A; Saúl, A, 2000) |
| "Thirty-five dermatologists enrolled 256 patients to assess the safety and efficacy of ketoconazole 2 percent cream, applied once daily, in the treatment of tinea pedis, tinea cruris, and tinea corporis." | 5.08 | Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis. ( Lester, M, 1995) |
| "A total of 40 patients with clinically and mycologically documented tinea corporis or tinea cruris were treated with 100 mg/day itraconazole (n = 19) or 500 mg/day griseofulvin (n = 21) for 15 days." | 5.07 | A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study. ( Chaidemenos, G; Chatzopoulou, E; Kalogeropoulou, A; Karakatsanis, G; Kousidou, T; Michailidis, D; Panagiotidou, D; Teknetzis, A, 1992) |
| "In an open study 58 patients with chronic dermatophytosis mainly caused by Trichophyton rubrum and five patients with Tinea capitis were treated with ketoconazole." | 5.05 | Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis. ( Svejgaard, E, 1985) |
| "A multicenter double-blind study was conducted on the use of ketoconazole and griseofulvin for the treatment of dermatomycoses." | 5.05 | A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses. ( Daily, AD; Glogau, R; Jolly, HW; Krupp, I; Rex, IH; Stegman, SJ; Tromovitch, TA, 1983) |
| " In this retrospective study, we aimed to analyze the response rate, efficacy, relapse rate, and side effects of oral ketoconazole (KZ) in the treatment of recalcitrant tinea corporis and cruris." | 4.02 | Real World Analysis of Response Rate and Efficacy of Oral Ketoconazole in Patients with Recalcitrant Tinea Corporis and Cruris. ( Arora, P; Kaur, R; Kulhari, A; Panesar, S; Rawat, D; Sardana, K, 2021) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 3.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| " A prolonged treatment by ketoconazole had a successful resolution in 70% of cases; 1 case of ciliar tinea caused by Trichophyton violaceum." | 3.71 | [Ocular parasitoses and mycoses: cases diagnosed in the Central University Hospital of Sfax between 1996 and 1999]. ( Ayadi, A; Ben Zina, Z; Cheikh-Rouhou, F; Ghorbel, R; Makni, F, 2001) |
| "The efficacy of ketoconazole was evaluated in forty-five patients with dermatophytoses, in twelve with candidosis, in two with fixed cutaneous sporotrichosis, in one with primary cutaneous cryptococcosis and in one with pulmonary aspergillosis." | 3.67 | Therapeutic experience with ketoconazole. ( Difonzo, EM; Palleschi, GM; Panconesi, E; Vannini, P, 1986) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 3.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| " In the latter group of infections the best results were obtained in patients with tinea corporis who were not responsive to griseofulvin." | 3.66 | Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies. ( Hay, RJ, 1983) |
| " Based on the pharmacokinetic profile, 100 mg itraconazole daily was then compared with 500 mg ultramicronized griseofulvin daily using a fixed treatment schedule of 15 days in tinea corporis and/or cruris and 30 days in tinea pedis and/or manus." | 2.67 | Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. ( Cauwenbergh, G; De Doncker, P; Janssen, PA; Lachapelle, JM; Tennstedt, D, 1992) |
| "Long-term safety and prevention of recurrence remain to be established." | 2.66 | Itraconazole therapy for recalcitrant dermatophyte infections. ( Hanifin, JM; Tofte, SJ, 1988) |
| "One ketoconazole-treated patient relapsed within 7 days after cessation of therapy." | 2.66 | Double blind study of ketoconazole and griseofulvin in dermatophytoses. ( Bartlett-Coma, A; Martínez-Roig, A; Torres-Rodríguez, JM, 1988) |
| "8%) over a mean treatment period from a minimum of 29 days (pityriasis versicolor) to a maximum of 39 days (tinea pedis) and 150 days (monilial granuloma), with a mean daily dosage of 200 mg in adults and 100 mg in children." | 2.66 | Ketoconazole: therapeutic results obtained in the district of Cagliari. ( Aste, N; Biggio, P; Mulas, P; Orru', A, 1986) |
| "album by food poisoning technique, disc diffusion and micro broth dilution assays." | 1.42 | The anti-dermatophyte activity of Allium hirtifolium Boiss aqueous extract. ( Kazempour, N; Mahboubi, M, 2015) |
| "Radiation port dermatophytosis is the occurrence of tinea corporis within the area of radiation therapy delivery." | 1.38 | Radiation port dermatophytosis: tinea corporis occurring at the site of irradiated skin. ( Casamiquela, KM; Cohen, PR, 2012) |
| "Outbreaks of dermatophytosis have been reported more and more frequently in combat sports such as wrestling and judo." | 1.38 | [Outbreak of dermatophytosis in a high-level French judo team: prospective study 2006/2011. Efficacy of a therapeutic protocol introduced in 2004/2005]. ( Estève, E; Lagier, L; Machet, L; Poisson, DM, 2012) |
| "which are among the agents of dermatophytosis with high morbidity, produce many virulence factors including hemolysins that exhibit toxic activity on immune system cells." | 1.37 | [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains]. ( Arslan, U; Fındık, D; Solgun, G; Türk Dağı, H, 2011) |
| "Voriconazole was the most and fluconazole was the less-active drug." | 1.34 | Antifungal susceptibility testing of Trichophyton rubrum by E-test. ( da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J, 2007) |
| "The ED(50) of R126638 in a mouse dermatophytosis model was more than fivefold lower than that of itraconazole." | 1.32 | In vitro and in vivo activities of the novel azole antifungal agent r126638. ( Ausma, J; Borgers, M; Heeres, J; Meerpoel, L; Odds, F; Van Gerven, F; Vanden Bossche, H; Woestenborghs, F, 2004) |
| "Ketoconazole was found to inhibit the growth of E." | 1.32 | Occurrence of dermatomycoses and in-vitro therapeutic efficacy of three antifungal drugs on the growth of Epidermophyton floccosum. ( Awoderu, VA; Nebo, GC; Otudero, VO, 2003) |
| "We report a case of Trichophyton mentagrophytes infection." | 1.32 | [Molecular biological analysis of Tinea faciei caused by a clinically anomalous strain of Trichophyton mentagrophytes]. ( Hiruma, M; Kaneko, C; Makimura, K; Ogawa, H; Yamaguchi, H, 2003) |
| "Dermatophytic disease is a chronic dermatophytosis involving the skin and viscera and caused by benign dermatophytes which cross the skin barrier." | 1.30 | [Dermatophytic disease: exuberant hyperkeratosis with cutaneous horns]. ( Boudghène-Stambouli, O; Mérad-Boudia, A, 1998) |
| "Thirty percent of the children may have dermatophytosis at sites other than the scalp." | 1.29 | Dermatophytosis of children in Kuwait: a prospective survey. ( al-Fouzan, AS; Kubec, K; Nanda, A, 1993) |
| "Treatment of experimental dermatophytosis in guinea pigs using 2." | 1.29 | Efficacy of 6-amino-2-n-pentylthiobenzothiazole on Trichophyton in vitro and in vivo. ( Bujdáková, H; Klobusický, M; Múcková, M; Sidóová, E, 1995) |
| "A case of dermatophytosis showing a kerion celsi reaction in the eyebrow of a forty-seven-year-old woman is reported." | 1.28 | Tinea of the eyebrow showing kerion celsi reaction: report of one case. ( Hiruma, M; Kawada, A; Kukita, A; Shimizu, T, 1991) |
| "Ketoconazole is a useful alternative to griseofulvin when oral therapy is required and the causative organism is insensitive to griseofulvin, or infection fails to respond to griseofulvin, or griseofulvin is contraindicated due to allergy, photosensitivity, porphyrinuria, intolerance, etc." | 1.27 | Consensus of the role and positioning of the imidazoles in the treatment of dermatophytosis. ( Jones, HE, 1986) |
| "Ketoconazole is an alternative when a replacement for griseofulvin is required, provided the degree of disability justifies the risk of drug toxicity." | 1.27 | Long-term ketoconazole treatment of chronic acral dermatophyte infections. ( Hersle, K; Mobacken, H; Moberg, S, 1985) |
| "Ketoconazole is a new antifungal drug, used for oral treatment, with a broad spectrum of activity." | 1.27 | Ketoconazole treatment in superficial mycoses. ( Cervetti, O; Forte, M; Puiatti, P; Zina, G, 1986) |
| "Oral treatment of dermatophytosis on guinea pig skin demonstrated that Tolciclate and Tolnaftate alleviated clinical symptoms and shortened the duration of the dermatophytosis, in comparison to nontreated controls." | 1.27 | Antifungal therapy of dermatophytosis in guinea pigs and congenitally athymic rats. ( Balish, E; Weber, J, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (43.82) | 18.7374 |
| 1990's | 22 (24.72) | 18.2507 |
| 2000's | 12 (13.48) | 29.6817 |
| 2010's | 14 (15.73) | 24.3611 |
| 2020's | 2 (2.25) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, P | 1 |
| Sardana, K | 1 |
| Kulhari, A | 1 |
| Kaur, R | 1 |
| Rawat, D | 1 |
| Panesar, S | 1 |
| Ansari, S | 1 |
| Ahmadi, B | 1 |
| Norouzi, M | 1 |
| Ansari, Z | 1 |
| Afsarian, MH | 1 |
| Lotfali, E | 1 |
| Rezaei-Matehkolaei, A | 1 |
| Salehi, Z | 1 |
| Fatahi, N | 1 |
| Taran, M | 1 |
| Izadi, A | 1 |
| Badali, H | 1 |
| Hashemi, SJ | 1 |
| Rezaie, S | 1 |
| Daie Ghazvini, R | 1 |
| Ghaffari, M | 1 |
| Aala, F | 1 |
| Barac, A | 1 |
| Khodavaisy, S | 1 |
| Chia, C | 1 |
| Dahl, MV | 1 |
| Gathings, RM | 1 |
| Abide, JM | 1 |
| Brodell, RT | 1 |
| Zhan, P | 1 |
| Li, ZH | 1 |
| Geng, C | 1 |
| Jiang, Q | 1 |
| Jin, Y | 1 |
| Dolatabadi, S | 1 |
| Liu, W | 1 |
| de Hoog, GS | 1 |
| Mahboubi, M | 1 |
| Kazempour, N | 1 |
| Moriello, KA | 1 |
| Maia Abinader, MV | 1 |
| Carvalho Maron, SM | 1 |
| Araújo, LO | 1 |
| Silva, Ado A | 1 |
| de Oliveira Lima, MI | 1 |
| Araújo de Medeiros, AC | 1 |
| Souza Silva, KV | 1 |
| Cardoso, GN | 1 |
| de Oliveira Lima, E | 1 |
| de Oliveira Pereira, F | 1 |
| Dalle, S | 1 |
| Toussaint, H | 1 |
| Thomas, L | 1 |
| Solgun, G | 1 |
| Fındık, D | 1 |
| Türk Dağı, H | 1 |
| Arslan, U | 1 |
| Veraldi, S | 1 |
| La Vela, V | 1 |
| Tavecchio, S | 1 |
| Shi, JP | 1 |
| Zhang, H | 1 |
| Zhang, ZD | 1 |
| Zhang, GH | 1 |
| Gao, AL | 1 |
| Xiang, SB | 1 |
| Casamiquela, KM | 1 |
| Cohen, PR | 1 |
| Lagier, L | 1 |
| Machet, L | 1 |
| Poisson, DM | 1 |
| Estève, E | 1 |
| Prigent, F | 1 |
| Kaneko, C | 1 |
| Hiruma, M | 2 |
| Ogawa, H | 1 |
| Makimura, K | 1 |
| Yamaguchi, H | 1 |
| Awoderu, VA | 1 |
| Nebo, GC | 1 |
| Otudero, VO | 1 |
| Odds, F | 1 |
| Ausma, J | 1 |
| Van Gerven, F | 1 |
| Woestenborghs, F | 1 |
| Meerpoel, L | 1 |
| Heeres, J | 1 |
| Vanden Bossche, H | 1 |
| Borgers, M | 1 |
| Pyun, MS | 1 |
| Shin, S | 1 |
| da Silva Barros, ME | 1 |
| de Assis Santos, D | 1 |
| Soares Hamdan, J | 1 |
| Méndez-Tovar, LJ | 1 |
| Manzano-Gayosso, P | 1 |
| Velásquez-Hernández, V | 1 |
| Millan-Chiu, B | 1 |
| Hernández-Hernández, F | 1 |
| Mondragón-González, R | 1 |
| López-Martínez, R | 1 |
| Balci, DD | 1 |
| Cetin, M | 1 |
| Kamalam, A | 1 |
| Thambiah, AS | 1 |
| Kavli, G | 1 |
| Midelfart, K | 1 |
| Moseng, D | 1 |
| Stenvold, SE | 1 |
| Falk, ES | 1 |
| Nilssen, JW | 1 |
| Volden, G | 1 |
| Laurberg, G | 1 |
| Zazgornik, J | 1 |
| Kopsa, H | 1 |
| Schmidt, P | 1 |
| Marosi, L | 1 |
| Balcke, P | 1 |
| Dompmartin, D | 1 |
| Caulaud, JP | 1 |
| Drouhet, E | 2 |
| Cox, FW | 1 |
| Stiller, RL | 1 |
| South, DA | 1 |
| Stevens, DA | 1 |
| Jones, HE | 2 |
| Hay, RJ | 3 |
| Dupont, B | 1 |
| Jolly, HW | 1 |
| Daily, AD | 1 |
| Rex, IH | 1 |
| Krupp, I | 1 |
| Tromovitch, TA | 1 |
| Stegman, SJ | 1 |
| Glogau, R | 1 |
| Stratigos, I | 1 |
| Zissis, NP | 1 |
| Katsambas, A | 1 |
| Koumentaki, E | 1 |
| Michalopoulos, M | 1 |
| Flemetakis, A | 1 |
| Valiant, ME | 1 |
| Frost, BM | 1 |
| Baker, RL | 1 |
| Para, MF | 1 |
| Schneck, DW | 1 |
| Bujdáková, H | 1 |
| Múcková, M | 1 |
| Klobusický, M | 1 |
| Sidóová, E | 1 |
| Lester, M | 1 |
| Stengel, F | 1 |
| Robles-Soto, M | 1 |
| Galimberti, R | 1 |
| Suchil, P | 1 |
| Goh, CL | 1 |
| Tay, YK | 1 |
| Ali, KB | 1 |
| Koh, MT | 1 |
| Seow, CS | 1 |
| Beller, M | 1 |
| Gessner, BD | 1 |
| Valsecchi, R | 1 |
| Pansera, B | 1 |
| di Landro, A | 1 |
| Cainelli, T | 1 |
| Liao, WQ | 1 |
| Li, ZG | 1 |
| Guo, M | 1 |
| Zhang, JZ | 1 |
| al-Fouzan, AS | 1 |
| Nanda, A | 1 |
| Kubec, K | 1 |
| Segal, R | 1 |
| Trattner, A | 1 |
| Alteras, I | 1 |
| Ingber, A | 1 |
| David, M | 1 |
| Sandbank, M | 1 |
| Kiska, DL | 1 |
| Cynamon, MH | 1 |
| Hernanz Hermosa, JM | 1 |
| Lázaro Ochaita, P | 1 |
| Smith, ES | 1 |
| Fleischer, AB | 1 |
| Feldman, SR | 1 |
| Boudghène-Stambouli, O | 3 |
| Mérad-Boudia, A | 3 |
| Howard, RM | 1 |
| Frieden, IJ | 1 |
| Shear, NH | 1 |
| Einarson, TR | 1 |
| Arikian, SR | 1 |
| Doyle, JJ | 1 |
| Finielz, P | 1 |
| Bonifaz, A | 1 |
| Saúl, A | 1 |
| Niewerth, M | 1 |
| Korting, HC | 1 |
| Cheikh-Rouhou, F | 1 |
| Makni, F | 1 |
| Ayadi, A | 1 |
| Ghorbel, R | 1 |
| Ben Zina, Z | 1 |
| Qiangqiang, Z | 1 |
| Limo, Q | 1 |
| Qixian, Q | 1 |
| Lachapelle, JM | 1 |
| De Doncker, P | 1 |
| Tennstedt, D | 1 |
| Cauwenbergh, G | 1 |
| Janssen, PA | 1 |
| Panagiotidou, D | 1 |
| Kousidou, T | 1 |
| Chaidemenos, G | 1 |
| Karakatsanis, G | 1 |
| Kalogeropoulou, A | 1 |
| Teknetzis, A | 1 |
| Chatzopoulou, E | 1 |
| Michailidis, D | 1 |
| Kawada, A | 1 |
| Shimizu, T | 1 |
| Kukita, A | 1 |
| Hazen, PG | 1 |
| Walker, AE | 1 |
| Stewart, JJ | 1 |
| Carney, JF | 1 |
| Engstrom, CW | 1 |
| Turgeon, KL | 1 |
| Katsitadze, AG | 1 |
| Khomasuridze, LA | 1 |
| Sharashenidze, VN | 1 |
| Mzhavanadze, NV | 1 |
| Svejgaard, E | 1 |
| Lapina, IZ | 1 |
| Leshchenko, VM | 1 |
| Bendikov, EA | 1 |
| Petrakov, AV | 1 |
| Mayou, SC | 1 |
| Calderon, RA | 1 |
| Goodfellow, A | 1 |
| Cervetti, O | 2 |
| Forte, M | 2 |
| Hanifin, JM | 1 |
| Tofte, SJ | 1 |
| Engelhard, D | 1 |
| Or, R | 1 |
| Naparstek, E | 1 |
| Leibovici, V | 1 |
| Van Hecke, E | 1 |
| Van Cutsem, J | 1 |
| Pizzino, D | 1 |
| Negosanti, M | 1 |
| Morganti, L | 1 |
| Patrizi, A | 1 |
| D'Antuono, A | 1 |
| Varotti, C | 1 |
| DeLauro, TM | 1 |
| Hodge, W | 1 |
| Richardson, K | 1 |
| Brammer, KW | 1 |
| Marriott, MS | 1 |
| Troke, PF | 1 |
| Hersle, K | 1 |
| Mobacken, H | 1 |
| Moberg, S | 1 |
| Panteleeva, GA | 1 |
| Nosyreva, NN | 1 |
| Bouali, O | 1 |
| Martínez-Roig, A | 1 |
| Torres-Rodríguez, JM | 1 |
| Bartlett-Coma, A | 1 |
| Dréno, B | 1 |
| Welin, J | 1 |
| Biggio, P | 1 |
| Aste, N | 1 |
| Mulas, P | 1 |
| Orru', A | 1 |
| Angarano, DW | 1 |
| Scott, DW | 1 |
| Difonzo, EM | 1 |
| Palleschi, GM | 1 |
| Vannini, P | 1 |
| Panconesi, E | 1 |
| Puiatti, P | 1 |
| Zina, G | 1 |
| Kamp, W | 1 |
| Schirren, C | 1 |
| Pettit, JH | 1 |
| Ichise, K | 1 |
| Tanio, T | 1 |
| Saji, I | 1 |
| Okuda, T | 1 |
| Weber, J | 1 |
| Balish, E | 1 |
4 reviews available for ketoconazole and Tinea
| Article | Year |
|---|---|
An unusual inflammatory rash.
Topics: Antifungal Agents; Cheek; Child, Preschool; Diagnosis, Differential; Exanthema; Female; Humans; Hydr | 2014 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chil | 1995 |
Dermatophyte infections in children.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; It | 1999 |
Pharmacoeconomic analysis of topical treatments for tinea infections.
Topics: Administration, Topical; Adult; Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Clotrimazol | 1995 |
14 trials available for ketoconazole and Tinea
| Article | Year |
|---|---|
Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial.
Topics: Administration, Topical; Adult; Antifungal Agents; Benzylisoquinolines; Drug Synergism; Drug Therapy | 2011 |
Trichophyton-rubrum-infected toenails treated with ketoconazole and partial nail avulsion.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Humans; Ketoconazole; Male; Middle Aged; | 1984 |
A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Chi | 1983 |
Ketoconazole compared with griseofulvin in dermatophytoses: a randomized, double-blind trial.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Double-Blind M | 1983 |
Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis.
Topics: Administration, Cutaneous; Adult; Female; Humans; Ketoconazole; Male; Middle Aged; Ointments; Tinea; | 1995 |
Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Topics: Adult; Candida; Candidiasis, Cutaneous; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; | 1994 |
Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antifungal Agents; Chi-Square Distribution; Chil | 2000 |
Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Double-Blind Method; Drug Admin | 1992 |
A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Griseofulvin; Humans; Itrac | 1992 |
Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis.
Topics: Administration, Oral; Adult; Child; Clinical Trials as Topic; Dermatomycoses; Double-Blind Method; G | 1985 |
Itraconazole therapy for recalcitrant dermatophyte infections.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recu | 1988 |
Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Griseofulvin; Hand Dermatos | 1988 |
Double blind study of ketoconazole and griseofulvin in dermatophytoses.
Topics: Child; Clinical Trials as Topic; Double-Blind Method; Griseofulvin; Humans; Ketoconazole; Tinea; Tin | 1988 |
Ketoconazole: therapeutic results obtained in the district of Cagliari.
Topics: Adolescent; Adult; Aged; Candidiasis, Cutaneous; Child; Child, Preschool; Clinical Trials as Topic; | 1986 |
71 other studies available for ketoconazole and Tinea
| Article | Year |
|---|---|
Real World Analysis of Response Rate and Efficacy of Oral Ketoconazole in Patients with Recalcitrant Tinea Corporis and Cruris.
Topics: Adult; Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Female; Humans; India; Ketocon | 2021 |
Topics: Antifungal Agents; Base Sequence; Epidermophyton; Humans; Iran; Itraconazole; Ketoconazole; Microbia | 2019 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; | 2020 |
Kerion mimicking erosive pustular dermatosis in elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Biopsy; Diagnosis, Differential; F | 2013 |
A chronic disseminated dermatophytosis due to Trichophyton violaceum.
Topics: Antifungal Agents; Base Sequence; DNA Fingerprinting; DNA, Fungal; DNA, Intergenic; Drug Therapy, Co | 2015 |
The anti-dermatophyte activity of Allium hirtifolium Boiss aqueous extract.
Topics: Allium; Antifungal Agents; Arthrodermataceae; Epidermophyton; Foodborne Diseases; Humans; Ketoconazo | 2015 |
In vitro efficacy of shampoos containing miconazole, ketoconazole, climbazole or accelerated hydrogen peroxide against Microsporum canis and Trichophyton species.
Topics: Animals; Cat Diseases; Cats; Disinfectants; Hair Preparations; Hydrogen Peroxide; Imidazoles; Ketoco | 2017 |
Tinea nigra dermoscopy: A useful assessment.
Topics: Administration, Topical; Adolescent; Antifungal Agents; Cladosporium; Dermoscopy; Hand Dermatoses; H | 2016 |
Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant Trichophyton rubrum.
Topics: Acyclic Monoterpenes; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; | 2017 |
[Acquired pigmented lesion of the foot].
Topics: Adolescent; Antifungal Agents; Dermoscopy; Female; Foot Dermatoses; Humans; Ketoconazole; Mitosporic | 2010 |
[Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
Topics: Antifungal Agents; Econazole; Hair; Hemolysis; Humans; Imidazoles; Itraconazole; Ketoconazole; Micro | 2011 |
Tinea capitis versus acne keloidalis nuchae with Trichophyton violaceum superinfection.
Topics: Acne Keloid; Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Drug Therapy | 2011 |
Radiation port dermatophytosis: tinea corporis occurring at the site of irradiated skin.
Topics: Adenocarcinoma; Aged; Antifungal Agents; Humans; Ketoconazole; Male; Prostatic Neoplasms; Radioderma | 2012 |
[Outbreak of dermatophytosis in a high-level French judo team: prospective study 2006/2011. Efficacy of a therapeutic protocol introduced in 2004/2005].
Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Dermatitis, Occupation | 2012 |
[Tinea].
Topics: Adolescent; Age Factors; Alopecia; Antifungal Agents; Child; Ciclopirox; Griseofulvin; Humans; Ketoc | 2002 |
[Molecular biological analysis of Tinea faciei caused by a clinically anomalous strain of Trichophyton mentagrophytes].
Topics: Administration, Oral; Administration, Topical; Adult; DNA, Intergenic; DNA, Ribosomal Spacer; Face; | 2003 |
Occurrence of dermatomycoses and in-vitro therapeutic efficacy of three antifungal drugs on the growth of Epidermophyton floccosum.
Topics: Antifungal Agents; Child; Epidermophyton; Female; Griseofulvin; Humans; Ketoconazole; Male; Microbia | 2003 |
In vitro and in vivo activities of the novel azole antifungal agent r126638.
Topics: Animals; Antifungal Agents; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Guinea Pigs; | 2004 |
Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazole.
Topics: Allium; Antifungal Agents; Drug Synergism; Humans; Ketoconazole; Microbial Sensitivity Tests; Phytot | 2006 |
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Keto | 2007 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Funga | 2007 |
Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Humans; Imidazoles; Itraco | 2008 |
Ketoconazole in the treatment of combined infection with dermatophytosis and candidosis.
Topics: Candidiasis, Cutaneous; Candidiasis, Oral; Child, Preschool; Humans; Ichthyosis; Ketoconazole; Male; | 1984 |
Ketoconazole in Trichophyton rubrum.
Topics: Adult; Antifungal Agents; Female; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Piperazines; | 1982 |
[Fungal infections -- always dangerous for immunosuppressed patients (author's transl)].
Topics: Adult; Candidiasis; Female; Humans; Imidazoles; Immunosuppression Therapy; Ketoconazole; Kidney Tran | 1981 |
[Fungal infection of the scalp by Trichophyton soudanense treated with ketoconazole (author's transl)].
Topics: Adult; Female; Humans; Imidazoles; Ketoconazole; Piperazines; Scalp Dermatoses; Senegal; Tinea | 1981 |
Oral ketoconazole for dermatophyte infections.
Topics: Administration, Oral; Antifungal Agents; Drug Eruptions; Female; Follow-Up Studies; Humans; Imidazol | 1982 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomyco | 1982 |
Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Dermatomycose | 1983 |
Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.
Topics: Adolescent; Adult; Antifungal Agents; Arthritis, Infectious; Blastomycosis; Candidiasis; Candidiasis | 1983 |
An experimental model for evaluation of antifungal agents in a Trichophyton mentagrophytes infection of guinea pigs.
Topics: Animals; Antifungal Agents; Clotrimazole; Disease Models, Animal; Female; Griseofulvin; Guinea Pigs; | 1984 |
Successful use of ketoconazole for invasive cutaneous Trichophyton rubrum infection.
Topics: Humans; Ketoconazole; Leukemia, Lymphoid; Male; Mercaptopurine; Middle Aged; Prednisone; Tinea | 1984 |
Therapeutic rounds. Ketoconazole in the treatment of tinea corporis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Humans; Ketoconazole; Male; Tinea | 1983 |
Efficacy of 6-amino-2-n-pentylthiobenzothiazole on Trichophyton in vitro and in vivo.
Topics: Animals; Antifungal Agents; Benzothiazoles; Clotrimazole; Guinea Pigs; Ketoconazole; Microbial Sensi | 1995 |
In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Epidermophyton; Female | 1994 |
An outbreak of tinea corporis gladiatorum on a high school wrestling team.
Topics: Adolescent; Alaska; Disease Outbreaks; Econazole; Griseofulvin; Humans; Ketoconazole; Male; Students | 1994 |
Contact dermatitis from ketoconazole.
Topics: Adult; Drug Eruptions; Female; Humans; Ketoconazole; Male; Patch Tests; Tinea; Tinea Versicolor | 1993 |
Candida zeylanoides causing candidiasis as tinea cruris.
Topics: Adult; Animals; Candida; Candidiasis; Culture Media; Female; Guinea Pigs; Humans; Ketoconazole; Male | 1993 |
Dermatophytosis of children in Kuwait: a prospective survey.
Topics: Animals; Animals, Domestic; Child; Child, Preschool; Clotrimazole; Dermatomycoses; Drug Therapy, Com | 1993 |
Once-weekly treatment with oral ketoconazole for superficial fungal infections.
Topics: Adult; Aged; Aged, 80 and over; Dermatomycoses; Drug Administration Schedule; Female; Humans; Ketoco | 1993 |
Photo quiz. Tinea barbae caused by Trichophyton verrucosum.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Erythromyci | 1997 |
Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994.
Topics: Administration, Topical; Ambulatory Care; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone | 1998 |
[Dermatophytic disease: exuberant hyperkeratosis with cutaneous horns].
Topics: Administration, Oral; Adult; Antifungal Agents; Biopsy; Diagnosis, Differential; Griseofulvin; Human | 1998 |
Tinea capitis in adult renal transplant recipient.
Topics: Adult; Animals; Antifungal Agents; Cats; Female; Humans; Ketoconazole; Kidney Transplantation; Middl | 1999 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomy | 2000 |
[Ocular parasitoses and mycoses: cases diagnosed in the Central University Hospital of Sfax between 1996 and 1999].
Topics: Adolescent; Adult; Alternaria; Animals; Aspergillus; Candida albicans; Eye Infections, Fungal; Eye I | 2001 |
Case report. Disseminated tinea of the verrucous type due to epidermophyton floccosum.
Topics: Antifungal Agents; Child; Epidermophyton; Humans; Ketoconazole; Male; Tinea | 2001 |
Tinea of the eyebrow showing kerion celsi reaction: report of one case.
Topics: Antifungal Agents; Diagnosis, Differential; Eyebrows; Female; Hair Diseases; Humans; Itraconazole; K | 1991 |
Keratitis, ichthyosis, and deafness (KID) syndrome: management with chronic oral ketoconazole therapy.
Topics: Administration, Oral; Adult; Candidiasis, Cutaneous; Carcinoma, Squamous Cell; Female; Foot Diseases | 1992 |
[The effect of nizoral and tinidazole on neutrophilic phagocytic activity in patients with rubromycosis and candidiasis].
Topics: Adolescent; Adult; Candida albicans; Candidiasis, Cutaneous; Dose-Response Relationship, Drug; Drug | 1990 |
[Antifungal agents in dermatophytic disease: failure of griseofulvin, ketoconazole and itraconazole].
Topics: Adult; Antifungal Agents; Dermatomycoses; Drug Therapy, Combination; Griseofulvin; Humans; Itraconaz | 1990 |
[Detoxifying function of the liver in patients with rubromycosis during treatment with antimycotics].
Topics: Adult; Antifungal Agents; Antipyrine; Female; Griseofulvin; Humans; Ketoconazole; Liver; Liver Funct | 1989 |
Deep (subcutaneous) dermatophyte infection presenting with unilateral lymphoedema.
Topics: Adolescent; Antifungal Agents; Female; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Lymph | 1987 |
[Treatment of dermatomycoses with a new antimycotic: itraconazole. Comparative studies of 2 posologic regimens].
Topics: Adolescent; Adult; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Ke | 1987 |
Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
Topics: Adult; Bone Marrow Transplantation; Drug Tolerance; Female; Humans; Itraconazole; Ketoconazole; Myel | 1988 |
[Therapeutic effectiveness of fenticonazole and evaluation of its in vitro antifungal activity compared to other imidazole derivatives].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Drug Evaluat | 1988 |
Current treatment of dermatophytoses.
Topics: Administration, Oral; Administration, Topical; Griseofulvin; Humans; Imidazoles; Ketoconazole; Onych | 1986 |
Consensus of the role and positioning of the imidazoles in the treatment of dermatophytosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Griseofulvin; Humans; Imidazoles; | 1986 |
Dermatophytosis. A review of diagnosis and current therapy.
Topics: Administration, Topical; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Griseofulvin; Humans; K | 1986 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; | 1985 |
Long-term ketoconazole treatment of chronic acral dermatophyte infections.
Topics: Female; Griseofulvin; Hand Dermatoses; Humans; Ketoconazole; Male; Middle Aged; Onychomycosis; Recur | 1985 |
[Experience with nizoral treatment of patients with rubromycosis and candidiasis].
Topics: Candidiasis, Cutaneous; Drug Evaluation; Humans; Ketoconazole; Tinea | 1988 |
[Dermatophytosis caused by Trichophyton violaceum. Apropos of a new case].
Topics: Adult; Alopecia; Humans; Ketoconazole; Lymphatic Diseases; Male; Tinea; Trichophyton | 1988 |
[A case for diagnosis: dermatophytosis of the face].
Topics: Diagnosis, Differential; Facial Dermatoses; Humans; Ketoconazole; Male; Middle Aged; Tinea | 1987 |
Use of ketoconazole in treatment of dermatophytosis in a dog.
Topics: Animals; Dog Diseases; Dogs; Female; Ketoconazole; Tinea | 1987 |
Therapeutic experience with ketoconazole.
Topics: Candidiasis, Vulvovaginal; Dermatomycoses; Female; Humans; Ketoconazole; Sporotrichosis; Tinea | 1986 |
Ketoconazole treatment in superficial mycoses.
Topics: Adolescent; Adult; Candidiasis, Cutaneous; Child; Child, Preschool; Dermatomycoses; Humans; Ketocona | 1986 |
[Observation of a case of dermatomycosis over a 25-year period. A contribution to the discussion of the concept of griseofulvin resistance].
Topics: Drug Resistance, Microbial; Epidermophyton; Griseofulvin; Humans; Ketoconazole; Male; Middle Aged; T | 1986 |
Treatment of superficial fungal infections.
Topics: Administration, Oral; Candidiasis; Dermatomycoses; Griseofulvin; Humans; Ketoconazole; Pityriasis; T | 1986 |
Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Vulvovaginal; Female; Guinea Pi | 1986 |
Antifungal therapy of dermatophytosis in guinea pigs and congenitally athymic rats.
Topics: Administration, Oral; Animals; Antifungal Agents; Female; Guinea Pigs; Ketoconazole; Mice; Rats; Rat | 1985 |